Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: Relevance to the etiology of Parkinson's disease

FASEB Journal

Volumn 17, Issue 13, 2003, Pages 1-25

  Gao, Hui Ming ^a   Liu, Bin ^a   Zhang, Wanqin ^a   Hong, Jau Shyong ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Inflammation; Microglia; NADPH oxidase; Synergistic neurotoxicity

Indexed keywords

EID: 84863135790     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.03-0203fje     Document Type: Article

References (67)

1. Olanow, C. W., and Tatton, W. G. (1999) Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22, 123-144 (Pubitemid 29144883)
2. Kidd, P. M. (2000) Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management. Altern. Med. Rev. 5, 502-529
3. Snyder, S. H., and D'Amato, R. J. (1985) Predicting Parkinson's disease. Nature 317, 198-199
4. Langston, J. W. (1985) MPTP neurotoxicity: an overview and characterization of phases of toxicity. Life Sci. 36, 201-206
5. Alam, M., and Schmidt, W. J. (2002) Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav. Brain Res. 136, 317-324 (Pubitemid 35246417)
6. Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., and Greenamyre, J. T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306
7. Thiruchelvam, M., Richfield, E. K., Baggs, R. B., Tank, A. W., and Cory-Slechta, D. A. (2000) The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J. Neurosci. 20, 9207-9214 (Pubitemid 32042923)
8. Ritz, B., and Yu, F. (2000) Parkinson's disease mortality and pesticide exposure in California 1984-1994. Int. J. Epidemiol. 29, 323-329 (Pubitemid 30209826)
9. Herishanu, Y. O., Medvedovski, M., Goldsmith, J. R., and Kordysh, E. (2001) A case-control study of Parkinson's disease in urban population of southern Israel. Can. J. Neurol. Sci. 28, 144-147 (Pubitemid 32521804)
10. Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., and Richardson, R. J. (1998) The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 50, 1346-1350 (Pubitemid 28240350)
11. Liou, H. H., Tsai, M. C., Chen, C. J., Jeng, J. S., Chang, Y. C., Chen, S. Y., and Chen, R. C. (1997) Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 48, 1583-1588
12. Rajput, A. H., and Uitti, R. J. (1987) Paraquat and Parkinson's disease. Neurology 37, 1820-1821
13. Semchuk, K. M., Love, E. J., and Lee, R. G. (1992) Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 42, 1328-1335
14. Liu, B., and Hong, J. S. (2003) Role of microglia in inflammation- mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 304, 1-7 (Pubitemid 36008905)
15. McGeer, P. L., Itagaki, S., Boyes, B. E., and McGeer, E. G. (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38, 1285-1291
16. Hirsch, E. C., Hunot, S., Damier, P., and Faucheux, B. (1998) Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann. Neurol. 44, S115-S120 (Pubitemid 28423837)
17. Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., and Karluk, D. (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1- methyl-4-phenyl-1,2,3,6- tetrahydropyridine exposure. Ann. Neurol. 46, 598-605 (Pubitemid 29466438)
18. Kurkowska-Jastrzebska, I., Wronska, A., Kohutnicka, M., Czlonkowski, A., and Czlonkowska, A. (1999) The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6- tetrahydropyridine intoxication in mouse. Exp. Neurol. 156, 50-61 (Pubitemid 29152982)
19. Akiyama, H., and McGeer, P. L. (1989) Microglial response to 6-hydroxydopamine-induced substantia nigra lesions. Brain Res. 489, 247-253 (Pubitemid 19149247)
20. Cicchetti, F., Brownell, A. L., Williams, K., Chen, Y. I., Livni, E., and Isacson, O. (2002) Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur. J. Neurosci. 15, 991-998 (Pubitemid 35463634)
21. Gao, H. M., Jiang, J., Wilson, B., Zhang, W., Hong, J. S., and Liu, B. (2002) Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J. Neurochem. 81, 1285-1297 (Pubitemid 34809262)
22. Castano, A., Herrera, A. J., Cano, J., and Machado, A. (1998) Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J. Neurochem. 70, 1584-1592 (Pubitemid 28136972)
23. Kim, W. G., Mohney, R. P., Wilson, B., Jeohn, G. H., Liu, B., and Hong, J. S. (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20, 6309-6316 (Pubitemid 30658427)
24. Iravani, M. M., Kashefi, K., Mander, P., Rose, S., and Jenner, P. (2002) Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration. Neuroscience 110, 49-58 (Pubitemid 34214759)
25. Liu, B., Jiang, J. W., Wilson, B. C., Du, L., Yang, S. N., Wang, J. Y., Wu, G. C., Cao, X. D., and Hong, J. S. (2000) Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. J. Pharmacol. Exp. Ther. 295, 125-132
26. Ling, Z., Gayle, D. A., Ma, S. Y., Lipton, J. W., Tong, C. W., Hong, J. S., and Carvey, P. M. (2002) In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov. Disord. 17, 116-124 (Pubitemid 36041267)
27. Casals, J., Elizan, T. S., and Yahr, M. D. (1998) Postencephalitic parkinsonism-a review. J. Neural Transm. 105, 645-676
28. Plassman, B. L., Havlik, R. J., Steffens, D. C., Helms, M. J., Newman, T. N., Drosdick, D., Phillips, C., Gau, B. A., Welsh-Bohmer, K. A., Burke, J. R., et al. (2000) Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology 55, 1158-1166
29. Ravenholt, R. T., and Foege, W. H. (1982) 1918 influenza, encephalitis lethargica, parkinsonism. Lancet 2, 860-864 (Pubitemid 12018557)
30. Williams, D. B., Annegers, J. F., Kokmen, E., O'Brien, P. C., and Kurland, L. T. (1991) Brain injury and neurologic sequelae: a cohort study of dementia, parkinsonism, and amyotrophic lateral sclerosis. Neurology 41, 1554-1557
31. Gao, H. M., Hong, J. S., Zhang, W., and Liu, B. (2003) Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. J. Neurosci. 23, 1228-1236 (Pubitemid 36258901)
32. Gao, H. M., Hong, J. S., Zhang, W., and Liu, B. (2002) Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J. Neurosci. 22, 782-790 (Pubitemid 34141759)
33. Liu, B., Du, L., Kong, L. Y., Hudson, P. M., Wilson, B. C., Chang, R. C., Abel, H. H., and Hong, J. S. (2000) Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures. Neuroscience 97, 749-756 (Pubitemid 30332182)
34. Fleckenstein, A. E., Metzger, R. R., Beyeler, M. L., Gibb, J. W., and Hanson, G. R. (1997) Oxygen radicals diminish dopamine transporter function in rat striatum. Eur. J. Pharmacol. 334, 111-114 (Pubitemid 27417818)
35. Park, S. U., Ferrer, J. V., Javitch, J. A., and Kuhn, D. M. (2002) Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons. J. Neurosci. 22, 4399-4405 (Pubitemid 37465656)
36. Hanson, G. R., Gibb, J. W., Metzger, R. R., Kokoshka, J. M., and Fleckenstein, A. E. (1998) Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: oxidative consequences? Ann. NY Acad. Sci. 844, 103-107 (Pubitemid 28367799)
37. McCormack, A. L., Thiruchelvam, M., Manning-Bog, A. B., Thiffault, C., Langston, J. W., Cory-Slechta, D. A., and Di Monte, D. A. (2002) Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol. Dis. 10, 119-127 (Pubitemid 34775465)
38. Suzuki, K., Mizuno, Y., and Yoshida, M. (1990) Effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-like compounds on mitochondrial respiration. Adv. Neurol. 53, 215-218
39. Suzuki, K., Mizuno, Y., Yamauchi, Y., Nagatsu, T., and Mitsuo, Y. (1992) Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4- tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain. J. Neurol. Sci. 109, 219-223
40. Beal, M. F. (2001) Experimental models of Parkinson's disease. Nat. Rev. Neurosci. 2, 325-334
41. Hunot, S., Dugas, N., Faucheux, B., Hartmann, A., Tardieu, M., Debre, P., Agid, Y., Dugas, B., and Hirsch, E. C. (1999) FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J. Neurosci. 19, 3440-3447 (Pubitemid 29203124)
42. Cassarino, D. S., Fall, C. P., Swerdlow, R. H., Smith, T. S., Halvorsen, E. M., Miller, S. W., Parks, J. P., Parker, W. D., Jr., and Bennett, J. P., Jr. (1997) Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim. Biophys. Acta 1362, 77-86 (Pubitemid 28027114)
43. Nagatsu, T., Mogi, M., Ichinose, H., and Togari, A. (2000) Changes in cytokines and neurotrophins in Parkinson's disease. J. Neural Transm. Suppl., 60, 277-290 (Pubitemid 32037200)
44. Liu, B., Gao, H. M., Wang, J. Y., Jeohn, G. H., Cooper, C. L., and Hong, J. S. (2002) Role of nitric oxide in inflammation-mediated neurodegeneration. Ann. NY Acad. Sci. 962, 318-331 (Pubitemid 34592321)
45. Nagatsu, T., Mogi, M., Ichinose, H., and Togari, A. (2000) Cytokines in Parkinson's disease. J. Neural Transm. Suppl. 58, 143-151
46. Hunot, S., Brugg, B., Ricard, D., Michel, P. P., Muriel, M. P., Ruberg, M., Faucheux, B. A., Agid, Y., and Hirsch, E. C. (1997) Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc. Natl. Acad. Sci. USA 94, 7531-7536 (Pubitemid 27345350)
47. Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., and O'Callaghan, J. P. (2002) Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease. FASEB J. 16, 1474-1476
48. Beckman, J. S., Carson, M., Smith, C. D., and Koppenol, W. H. (1993) ALS, SOD and peroxynitrite. Nature 364, 584
49. Xie, Z., Wei, M., Morgan, T. E., Fabrizio, P., Han, D., Finch, C. E., and Longo, V. D. (2002) Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia. J. Neurosci. 22, 3484-3492 (Pubitemid 37465754)
50. Vila, M., Jackson-Lewis, V., Guegan, C., Wu, D. C., Teismann, P., Choi, D. K., Tieu, K., and Przedborski, S. (2001) The role of glial cells in Parkinson's disease. Curr. Opin. Neurol. 14, 483-489 (Pubitemid 32703541)
51. Chao, C. C., Hu, S., Molitor, T. W., Shaskan, E. G., and Peterson, P. K. (1992) Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149, 2736-2741
52. Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., and Przedborski, S. (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 5, 1403-1409
53. Dehmer, T., Lindenau, J., Haid, S., Dichgans, J., and Schulz, J. B. (2000) Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J. Neurochem. 74, 2213-2216 (Pubitemid 30217680)
54. Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L., et al. (2001) Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 98, 14669-14674 (Pubitemid 33121449)
55. Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D. K., Ischiropoulos, H., and Przedborski, S. (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22, 1763-1771 (Pubitemid 35386294)
56. Przedborski, S., Jackson-Lewis, V., Yokoyama, R., Shibata, T., Dawson, V. L., and Dawson, T. M. (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA 93, 4565-4571
57. Schulz, J. B., Matthews, R. T., Muqit, M. M., Browne, S. E., and Beal, M. F. (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64, 936-939
58. Hantraye, P., Brouillet, E., Ferrante, R., Palfi, S., Dolan, R., Matthews, R. T., and Beal, M. F. (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat. Med. 2, 1017-1021 (Pubitemid 26306841)
59. Babior, B. M. (1999) NADPH oxidase: an update. Blood 93, 1464-1476
60. Li, Y., and Trush, M. A. (1998) Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem. Biophys. Res. Commun. 253, 295-299 (Pubitemid 29026697)
61. Irani, K., Xia, Y., Zweier, J. L., Sollott, S. J., Der, C. J., Fearon, E. R., Sundaresan, M., Finkel, T., and Goldschmidt-Clermont, P. J. (1997) Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275, 1649-1652 (Pubitemid 27120541)
62. Tammariello, S. P., Quinn, M. T., and Estus, S. (2000) NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons. J. Neurosci. 20, RC53
63. Noh, K. M., and Koh, J. Y. (2000) Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J. Neurosci. 20, RC111
64. Chan, P., DeLanney, L. E., Irwin, I., Langston, J. W., and Di Monte, D. (1991) Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain. J. Neurochem. 57, 348-351
65. Jenner, P. (1998) Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov. Disord. 13, 24-34
66. Greenamyre, J. T., MacKenzie, G., Peng, T. I., and Stephans, S. E. (1999) Mitochondrial dysfunction in Parkinson's disease. Biochem. Soc. Symp. 66, 85-97 (Pubitemid 129639025)
67. Hasegawa, E., Takeshige, K., Oishi, T., Murai, Y., and Minakami, S. (1990) 1-Methyl-4- phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem. Biophys. Res. Commun. 170, 1049-1055 (Pubitemid 20273373)